Brevetti, G., di Lisa, F., Perna, S., Menabo, R., Barbato, R., Martone, V
A mechanism of action phase 1 study showed that the glycemic efficacy of tirzepatide in T2DM results from concurrent improvements in key components of diabetes pathophysiology, including -cell function, insulin sensitivity, and glucagon secretion (135)
Sports Research Honorable mention Sports Research didnt earn a top recommendation in our summary toward the top of the page, but it just narrowly missed being our preferred vegan option
Why Nutrition Priorities Change on a GLP-1 GLP-1 medications work in part by slowing digestion and reducing appetite, which means most people eat noticeably less overall
F.YuR.et al (2021b)
7, 2023 Novartis AG has synthesized glucagon-like peptide 1 receptor (GLP-1R) agonists reported to be useful for the treatment of type 2 diabetes, obesity, hypertension, stroke, hyperglycemia, dyslipidemia, nonalcoholic steatohepatitis and diabetic nephropathy, among others